A Prospective Study of Anti-PD-1 Inhibitors Therapy in Combination With Incomplete Thermal Ablation in Patients With Advanced Hepatocellular Carcinoma
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary) ; Toripalimab (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 16 Aug 2019 Status changed from recruiting to completed.
- 10 May 2019 New trial record